CareDx, Inc. (CDNA): Price and Financial Metrics


CareDx, Inc. (CDNA): $37.93

0.47 (+1.25%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

CDNA POWR Grades


  • Quality is the dimension where CDNA ranks best; there it ranks ahead of 66.2% of US stocks.
  • The strongest trend for CDNA is in Growth, which has been heading down over the past 161 days.
  • CDNA ranks lowest in Momentum; there it ranks in the 10th percentile.

CDNA Stock Summary

  • With a one year PEG ratio of 1,033.61, CareDx Inc is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 97.21% of US stocks.
  • CDNA's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of only 12.26% of US stocks.
  • Revenue growth over the past 12 months for CareDx Inc comes in at 62.85%, a number that bests 88.8% of the US stocks we're tracking.
  • Stocks with similar financial metrics, market capitalization, and price volatility to CareDx Inc are IDN, TENB, ESTC, AMWL, and OM.
  • Visit CDNA's SEC page to see the company's official filings. To visit the company's web site, go to www.caredx.com.

CDNA Valuation Summary

  • In comparison to the median Healthcare stock, CDNA's price/sales ratio is 33.92% higher, now standing at 15.2.
  • CDNA's price/sales ratio has moved up 10.9 over the prior 87 months.
  • CDNA's price/sales ratio has moved up 10.9 over the prior 87 months.

Below are key valuation metrics over time for CDNA.

Stock Date P/S P/B P/E EV/EBIT
CDNA 2021-08-31 15.2 8.0 -431.0 -354.3
CDNA 2021-08-30 16.7 8.8 -473.6 -392.4
CDNA 2021-08-27 16.6 8.8 -469.6 -388.8
CDNA 2021-08-26 16.0 8.5 -454.2 -375.1
CDNA 2021-08-25 16.0 8.5 -454.1 -375.0
CDNA 2021-08-24 16.2 8.6 -459.0 -379.3

CDNA Growth Metrics

    Its 4 year price growth rate is now at 523.59%.
  • The year over year net cashflow from operations growth rate now stands at 6541.86%.
  • Its 2 year price growth rate is now at 127.42%.
CDNA's revenue has moved up $199,252,000 over the prior 33 months.

The table below shows CDNA's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-09-30 275.821 -16.279 -18.026
2021-06-30 253.601 -11.454 -8.947
2021-03-31 221.214 2.856 -13.578
2020-12-31 192.194 33.431 -18.714
2020-09-30 169.371 25.167 -19.976
2020-06-30 149.813 20.565 -18.971

CDNA's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • CDNA has a Quality Grade of C, ranking ahead of 63.01% of graded US stocks.
  • CDNA's asset turnover comes in at 0.543 -- ranking 49th of 81 Healthcare stocks.
  • MGLN, OPGN, and LH are the stocks whose asset turnover ratios are most correlated with CDNA.

The table below shows CDNA's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-09-30 0.543 0.676 -0.174
2021-06-30 0.557 0.680 -0.105
2021-03-31 0.550 0.673 -0.201
2020-12-31 0.628 0.672 -0.382
2020-09-30 0.673 0.664 -0.802
2020-06-30 0.751 0.655 -1.009

CDNA Price Target

For more insight on analysts targets of CDNA, see our CDNA price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $107.33 Average Broker Recommendation 1.36 (Strong Buy)

CDNA Stock Price Chart Interactive Chart >

Price chart for CDNA

CDNA Price/Volume Stats

Current price $37.93 52-week high $96.88
Prev. close $37.46 52-week low $37.32
Day low $37.65 Volume 652,270
Day high $40.69 Avg. volume 747,213
50-day MA $43.49 Dividend yield N/A
200-day MA $67.38 Market Cap 2.00B

CareDx, Inc. (CDNA) Company Bio


CareDx, Inc. focuses on the discovery, development, and commercialization of diagnostic surveillance solutions for transplant patients in North America, Europe, the Middle East, Africa, and Latin America. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. CareDx, Inc. was incorporated in 1998 and is based in Brisbane, California.


CDNA Latest News Stream


Event/Time News Detail
Loading, please wait...

CDNA Latest Social Stream


Loading social stream, please wait...

View Full CDNA Social Stream

Latest CDNA News From Around the Web

Below are the latest news stories about CareDx Inc that investors may wish to consider to help them evaluate CDNA as an investment opportunity.

Mesirow Financial Investment Management, Inc. ...

Investment company Mesirow Financial Investment Management, Inc. (Current Portfolio) buys Green Brick Partners Inc, Cadre Holdings Inc, Identiv Inc, Atlanticus Holdings Corp, Andersons Inc, sells TriState Capital Holdings Inc, The Joint Corp, Mirum Pharmaceuticals Inc, Genasys Inc, CareDx Inc during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Mesirow Financial Investment Management, Inc..

Yahoo | January 14, 2022

Landmark ADMIRAL Study Publication with CareDx’s AlloSure Kidney is the First Long-Term Multicenter Prospective Clinical Validation for Routine Organ Transplant Surveillance

ADMIRAL Study Shows AlloSure Detects Clinical and Subclinical ABMR and TCMR, and Predicts Long-Term Outcomes for Kidney Transplant Patients AlloSure Showed 62% Improvement Over Standard of Care Serum Creatinine SOUTH SAN FRANCISCO, Calif., Jan. 12, 2022 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value diagnostic solutions for transplant patients – today announced the pub

Yahoo | January 12, 2022

CareDx (CDNA) Gets a Hold Rating from H.C. Wainwright

In a report released today, Yi Chen from H.C. Wainwright reiterated a Hold rating on CareDx (CDNA – Research Report). The company's shares closed last Monday at $46.29, close to its 52-week low of $39.16. According to TipRanks.com, Chen is a 5-star analyst with an average return of 24.9% and a 38.8% success rate. Chen covers the Healthcare sector, focusing on stocks such as Ortho Clinical Diagnostics Holdings, Interpace Diagnostics Group, and HTG Molecular Diagnostics. CareDx has an analyst consensus of Strong Buy, with a price target consensus of $98.67.

Christine Brown on TipRanks | January 11, 2022

CareDx Partners with Multiple Biotechnology Companies to Use AlloCell in CAR T-Cell Therapy Clinical Studies

AlloCell Will Be Used to Monitor the Expansion and Persistence of Allogeneic Cell Therapies in Clinical Development for Use in OncologySOUTH SAN FRANCISCO, Calif., Jan. 11, 2022 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced recent drug development collaborations with three leading cell thera

Yahoo | January 11, 2022

CareDx Reports Preliminary Revenue Results for Fourth Quarter and Full Year 2021

Another Record Revenue Quarter Caps Off Strong YearSOUTH SAN FRANCISCO, Calif., Jan. 10, 2022 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA) -- The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today reported preliminary financial results for the fourth quarter and full year ended December 31, 2021. Fourth Quarter Highlights Revenue expected to be between $78

Yahoo | January 10, 2022

Read More 'CDNA' Stories Here

CDNA Price Returns

1-mo -16.53%
3-mo -47.38%
6-mo -55.63%
1-year -60.32%
3-year 54.06%
5-year 1,387.45%
YTD -16.60%
2021 -37.23%
2020 235.88%
2019 -14.20%
2018 242.51%
2017 171.85%

Continue Researching CDNA

Want to see what other sources are saying about CareDx Inc's financials and stock price? Try the links below:

CareDx Inc (CDNA) Stock Price | Nasdaq
CareDx Inc (CDNA) Stock Quote, History and News - Yahoo Finance
CareDx Inc (CDNA) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 1.4988 seconds.